Use of Direct-to-Consumer Telemedicine to Access Mental Health Services

J Gen Intern Med. 2022 Aug;37(11):2759-2767. doi: 10.1007/s11606-021-07326-y. Epub 2022 Jan 29.

Abstract

Background: The coronavirus disease 2019 pandemic has contributed to growing demand for mental health services, but patients face significant barriers to accessing care. Direct-to-consumer(DTC) telemedicine has been proposed as one way to increase access, yet little is known about its pre-pandemic use for mental healthcare.

Objective: To characterize patients, providers, and their use of a large nationwide DTC telemedicine platform for mental healthcare.

Design: Retrospective cross-sectional study.

Setting: Mental health encounters conducted on the American Well DTC telemedicine platform from 2016 to 2018.

Participants: Patients and physicians.

Main measures: Patient measures included demographics, insurance report, and number of visits. Provider characteristics included specialty, region, and number of encounters. Encounter measures included wait time, visit length and timing, out-of-pocket payment, coupon use, prescription outcome, referral receipt, where care otherwise would have been sought, and patient satisfaction. Factors associated with five-star physician ratings and prescription receipt were assessed using logistic regression.

Key results: We analyzed 19,270 mental health encounters between 6708 patients and 1045 providers. Visits were most frequently for anxiety (39.1%) or depression (32.5%), with high satisfaction (4.9/5) across conditions. Patients had a median 2.0 visits for psychiatry (IQR 1.0-3.0) and therapy (IQR 1.0-5.0), compared to 1.0 visit (IQR 1.0-1.0) for urgent care. High satisfaction was positively correlated with prescription receipt (OR 1.89, 95% CI 1.54-2.32) and after-hours timing (aOR 1.18, 95% CI 1.02-1.36). Prescription rates ranged from 79.6% for depression to 32.2% for substance use disorders. Prescription receipt was associated with increased visit frequency (aOR 1.95, 95% CI 1.57-2.42 for ≥ 3 visits).

Conclusions: As the burden of psychiatric disease grows, DTC telemedicine offers one solution for extending access to mental healthcare. While most encounters were one-off, evidence of some continuity in psychiatry and therapy visits-as well as overall high patient satisfaction-suggests potential for broader DTC telemental health use.

MeSH terms

  • COVID-19* / epidemiology
  • COVID-19* / therapy
  • Cross-Sectional Studies
  • Humans
  • Mental Health Services*
  • Patient Satisfaction
  • Retrospective Studies
  • Telemedicine*